Status:
TERMINATED
Naltrexone Implants as Relapse Prevention
Lead Sponsor:
University of Oslo
Conditions:
Opioid Dependency
Eligibility:
All Genders
19+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this clinical trial is to study the efficacy and safety of naltrexone implants as relapse prevention for patients that are completing treatment for opiate addiction in inpatient (or sim...
Eligibility Criteria
Inclusion
- soon to complete inpatient treatment for opioid addiction
- living in southern Norway
Exclusion
- psychosis / major depression, currently not treated
- pregnancy
- liver enzymes: ASAT or ALAT \> threefold above upper boundary
- maintenance treatment with methadone or buprenorphine
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2006
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT00269607
Start Date
May 1 2005
End Date
December 1 2006
Last Update
December 11 2013
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.